Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

tRNA-m1A modification promotes T cell expansion via efficient MYC protein synthesis
Yongbo Liu, Jing Zhou, Xiaoyu Li, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1433-1444
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 66
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 44
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 16
tRNA modifications: insights into their role in human cancers
Ye Wang, En‐Wei Tao, Juan Tan, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 29
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Emerging Roles of RNA Methylation in Development
Mengke Wang, Chun‐Chun Gao, Yun‐Gui Yang
Accounts of Chemical Research (2023) Vol. 56, Iss. 23, pp. 3417-3427
Closed Access | Times Cited: 27
tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
Weifang Cui, Deze Zhao, Junjie Jiang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1146-1162
Open Access | Times Cited: 24
Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape
Yuxin Kong, Jie Yu, Shengfang Ge, et al.
The Innovation (2023) Vol. 4, Iss. 4, pp. 100452-100452
Open Access | Times Cited: 24
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
Ana M. Añazco-Guenkova, Borja Miguel‐López, Óscar Monteagudo-García, et al.
NAR Cancer (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Translation-dependent and -independent mRNA decay occur through mutually exclusive pathways defined by ribosome density during T cell activation
Blandine C. Mercier, Emmanuel Labaronne, David Cluet, et al.
Genome Research (2024)
Open Access | Times Cited: 9
Comparative analysis of 43 distinct RNA modifications by nanopore tRNA sequencing
Laura K. White, Kezia Dobson, Samantha del Pozo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
Huanxiang Chen, Hongyang Liu, Chenxing Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
Quantitative RNA pseudouridine maps reveal multilayered translation control through plant rRNA, tRNA and mRNA pseudouridylation
Haoxuan Li, Guanqun Wang, Chang Ye, et al.
Nature Plants (2025)
Closed Access | Times Cited: 1
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy
Dian Xiong, Lu Zhang, Zhi‐Jun Sun
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond
Jiarong Zheng, Ye Lu, Yunfan Lin, et al.
Cell Death and Differentiation (2023) Vol. 31, Iss. 1, pp. 9-27
Closed Access | Times Cited: 17
m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling
Shu‐Jin Li, Feng Tian, Yuan‐Tong Liu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Advances in the Structural and Functional Understanding of m1A RNA Modification
Jakub Smoczynski, Marcel-Joseph Yared, Vincent Meynier, et al.
Accounts of Chemical Research (2024)
Open Access | Times Cited: 6
tRNA m1A modification regulate HSC maintenance and self-renewal via mTORC1 signaling
Hongna Zuo, Aiwei Wu, Mingwei Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
N6‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
Jian Pu, Zuoming Xu, Youguan Huang, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3649-3665
Open Access | Times Cited: 13
Post-transcriptional checkpoints in autoimmunity
Rami Bechara, Stéphan Vagner, Xavier Mariette
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 8, pp. 486-502
Closed Access | Times Cited: 11
ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
Junting Zhang, Yiying Li, Jianchao Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4840-4855
Open Access | Times Cited: 11
New directions for Ψ and m1A decoding in mRNA: deciphering the stoichiometry and function
Meiling Zhang, Xiaoting Zhang, Yichen Ma, et al.
RNA (2024) Vol. 30, Iss. 5, pp. 537-547
Open Access | Times Cited: 4
Methylation modifications in tRNA and associated disorders: Current research and potential therapeutic targets
Zhijing Wu, Ruixin Zhou, Baizao Li, et al.
Cell Proliferation (2024) Vol. 57, Iss. 9
Open Access | Times Cited: 4
A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer
Feiyu Qin, Zehua Bian, Lingzhen Jiang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2119-2132
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top